Literature DB >> 33095325

[Primary extra-axial chondroid chordoma of the anterior nasal septum: case report of a rare chordoma with literature review].

C Holley1, T Breining2, M Scheithauer3, P Möller4, T F E Barth4.   

Abstract

An 87-year-old patient reported a nodular, progressively enlarging mass of the anterior nasal septum leading to partial obstruction of the nostrils. The tumor showed no infiltration of the subcutis, bone, or paranasal sinuses in imaging or intraoperatively. Histological examination revealed a chondroid tumor with lobular growth and physaliferous cell morphology. Immunohistochemistry revealed a brachyury-positive tumor without EWSR1 rearrangement, leading to the diagnosis of a chondroid chordoma. The reported case demonstrates the differential diagnostic considerations pertaining to this rare tumor, which can also have an untypical and very rare extra-axial location. Review of the literature identified 34 primary extraosseous chordomas of the nose, nasopharynx, and paranasal sinuses, and allowed the nasal chordoma presented herein to be included in this group of extra-axial chordomas.

Entities:  

Keywords:  Axial skeleton; Brachyury; Differential diagnosis; Immunohistochemistry; Nasal tumor

Mesh:

Year:  2020        PMID: 33095325     DOI: 10.1007/s00106-020-00957-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  1 in total

1.  Chordoma. An immunohistochemical study of 20 cases.

Authors:  J M Meis; A A Giraldo
Journal:  Arch Pathol Lab Med       Date:  1988-05       Impact factor: 5.534

  1 in total
  1 in total

1.  Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.

Authors:  Xiaoyun Wen; Robert Cimera; Ruth Aryeequaye; Mohanty Abhinta; Edward Athanasian; John Healey; Nicola Fabbri; Patrick Boland; Yanming Zhang; Meera Hameed
Journal:  Genes Chromosomes Cancer       Date:  2021-08-26       Impact factor: 5.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.